Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pronase for Chromoendoscopy Screening in Esophageal Cancer
NCT02030769Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of pronase in esophageal cancer (2 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Detection rate of high grade dysplasia and carcinoma in iodine void lesion at 1 week. Started Jan 2014; status: completed.
02
Drugs
pronase
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02030769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030769.